Pharmacokinetics of whole IgG equine antivenom: Comparison between normal and envenomed rabbits

Toxicon

Volumn 48, Issue 3, 2006, Pages 255-263

  Quesada, Lil ^a   Sevcik, Carlos ^b   Lomonte, Bruno ^a   Rojas, Ermila ^a   Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Antivenom; Envenoming; IgG; Pharmacokinetics

Indexed keywords

IMMUNOGLOBULIN G; SNAKE VENOM; TOXIN ANTIBODY; VENOM ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; EDEMA; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAVASATION; MICROANGIOPATHY; NONHUMAN; PRIORITY JOURNAL; RABBIT; TISSUE DISTRIBUTION;

ANIMALS; ANTIVENINS; HORSES; IMMUNE SERA; IMMUNOGLOBULIN G; RABBITS; VIPER VENOMS;

ANIMALIA; BOTHRIECHIS LATERALIS; CROTALINAE; EQUIDAE; MICRURUS NIGROCINCTUS; ORYCTOLAGUS CUNICULUS; VIPERIDAE;

EID: 33746973241     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2006.05.010     Document Type: Article

References (25)

1. Ariaratnam C.A., Sjostrom L., Raziek Z., Kularatne A.M., Arachchi R.W.K.K., Sheriff M.H.R., Theakston R.D.G., and Warrell D.A. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 74-80
2. Arroyo O., Rojas G., and Gutiérrez J.M. Envenenamiento por mordedura de serpiente en Costa Rica en 1996: epidemiología y consideraciones clínicas. Acta Médica Costarricense 41 (1999) 23-29
3. Battellino C., Piazza R., da Silva A.M.M., Cury Y., and Farsky S.H.P. Assessment of efficacy of bothropic antivenom therapy on microcirculatory effects induced by Bothrops jararaca snake venom. Toxicon 41 (2003) 583-593
4. Brobeck J.R. Best & Taylor's Physiological Basis of Medical Practice. 10th ed. (1979), Williams & Wilkins, Baltimore
5. Dart R.C., Seifert S.A., Boyer L.V., Clark R.F., Hall E., McKinney P., McNally J., Kitchens C.S., Curry S.C., Bogdan G.M., Ward S.B., and Porter R.S. A randomized multicenter trial of Crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch. Intern. Med. 161 (2001) 2030-2036
6. Gené J.A., Roy A., Rojas G., Gutiérrez J.M., and Cerdas L. Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon 27 (1989) 841-848
7. Gibaldi M., and Perrier D. Pharmacokinetics. second ed. (1982), Marcel Dekker, New York
8. Gutiérrez J.M. Clinical toxicology of snake bite in Central America. In: Meier J., and White J. (Eds). Handbook of Clinical Toxicology of Animal Venoms and Poisons (1995), CRC Press, Florida 645-665
9. Gutiérrez J.M., and Lomonte B. Efectos locales en el envenenamiento ofídico en América Latina. In: Cardoso J.L.C., Franca F.O.S., Wen F.H., Málaque C.M.S., and Daddad V. (Eds). Animais Peconhentos no Brasil. Biologia, Clínica e Terapéutica dos Acidentes (2003), Sarvier, Sao Paulo 310-323
10. Gutiérrez J.M., Ownby C.L., and Odell G.V. Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper. Exp. Mol. Pathol. 40 (1984) 367-379
11. Gutiérrez J.M., Gené J.A., Rojas G., and Cerdas L. Neutralization of proteolytic and hemorrhagic activities of Costa Rican snake venoms by a polyvalent antivenom. Toxicon 23 (1985) 887-893
12. Gutiérrez J.M., Rojas G., Lomonte B., Gené J.A., and Cerdas L. Comparative study of the edema-forming activity of Costa Rican snake venoms and its neutralization by a polyvalent antivenom. Comp. Biochem. Physiol. 85C (1986) 171-175
13. Gutiérrez J.M., León G., and Lomonte B. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenoming. Clin. Pharmacokinet. 42 (2003) 721-741
14. Hollander M., and Wolfe D.A. Nonparametic Statistical Procedure (1973), Wiley, New York
15. 2 and Fab of the antivenin. Toxicon 36 (1998) 93-114
16. Lalloo D.G., and Theakston R.D.G. Snake antivenoms. J. Toxicol. Clin. Toxicol. 41 (2003) 277-290
17. 2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom. Am. J. Trop. Med. Hyg. 61 (1999) 266-271
18. 2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom, extravasation to muscle tissue, and potential for induction of adverse reactions. Toxicon 39 (2001) 793-801
19. Lobo E.D., Hansen R.J., and Balthasar J.P. Antibody pharmacokinetics and pharmacodynamics. J. Pharmaceut. Sci. 93 (2004) 2645-2668
20. Nelder J., and Mead R. A simplex method for function minimization. Comp. J. 7 (1965) 308-313
21. 2-scorpion venom interactions. Toxicol. Appl. Pharmacol. 141 (1996) 272-277
22. Rivière G., Choumet V., Audebert F., Sabouraud A., Debray M., Scherrmann J.M., and Bon C. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J. Pharmacol. Exp. Ther. 281 (1997) 1-8
23. Rojas G., Jiménez J.M., and Gutiérrez J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon 32 (1994) 351-363
24. Warrell D.A. Snakebites in Central and South America: epidemiology, clinical features, and clinical management. In: Campbell J.A., and Lamar W.W. (Eds). The Venomous Reptiles of the Western Hemisphere vol. II (2004), Comstock, Ithaca 709-761
25. White J. Snake venoms and coagulopathy. Toxicon 45 (2005) 951-967